D-Luciferin

CAS No. 2591-17-5

D-Luciferin ( Firefly Luciferin )

Catalog No. M13783 CAS No. 2591-17-5

D-Luciferin is a popular bioluminescent substrate of luciferase in the presence of ATP, used in luciferase-based bioluminescence imaging and cell-based high-throughput screening applications.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 41 In Stock
50MG 74 In Stock
100MG 107 In Stock
200MG 160 In Stock
500MG 268 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    D-Luciferin
  • Note
    Research use only, not for human use.
  • Brief Description
    D-Luciferin is a popular bioluminescent substrate of luciferase in the presence of ATP, used in luciferase-based bioluminescence imaging and cell-based high-throughput screening applications.
  • Description
    D-Luciferin is a popular bioluminescent substrate of luciferase in the presence of ATP, used in luciferase-based bioluminescence imaging and cell-based high-throughput screening applications.
  • Synonyms
    Firefly Luciferin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    2591-17-5
  • Formula Weight
    280.32
  • Molecular Formula
    C11H8N2O3S2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 56 mg/mL (199.77 mM), Ethanol: 1 mg/mL (3.56 mM)
  • SMILES
    O=C([C@@H]1N=C(C2=NC3=CC=C(O)C=C3S2)SC1)O
  • Chemical Name
    (4S)-2-(6-hydroxy-1,3-benzothiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hauber R, et al. J Clin Chem Clin Biochem. 1987, 25(8), 511-514.
molnova catalog
related products
  • Chlorotoxin TFA (163...

    Chlorotoxin TFA is a polypeptide derived from scorpion poison and ACTS as a chloride channel blocker.

  • AS101

    AS101, a potent in vitro and in vivo immunomodulator, is a novel inhibitor of IL-1beta converting enzyme.

  • Lanreotide acetate

    Lanreotide acetate is a somatostatin analogue with antineoplastic activity used for carcinoid syndrome.